Raymond James Trust’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.32M | Buy |
10,387
+337
| +3% | +$74.1K | 0.05% | 297 |
|
|
2024
Q2 | $2.05M | Buy |
10,050
+105
| +1% | +$21.4K | 0.05% | 312 |
|
|
2024
Q1 | $2.17M | Sell |
9,945
-13
| -0.1% | -$2.86K | 0.05% | 304 |
|
|
2023
Q4 | $2.26M | Sell |
9,958
-731
| -7% | -$154K | 0.06% | 271 |
|
|
2023
Q3 | $2.15M | Sell |
10,689
-785
| -7% | -$166K | 0.06% | 260 |
|
|
2023
Q2 | $2.38M | Buy |
11,474
+609
| +6% | +$118K | 0.07% | 241 |
|
|
2023
Q1 | $2.14M | Buy |
10,865
+162
| +2% | +$33.3K | 0.07% | 237 |
|
|
2022
Q4 | $2.17M | Buy |
10,703
+487
| +5% | +$95.2K | 0.07% | 238 |
|
|
2022
Q3 | $1.8M | Buy |
10,216
+1,292
| +14% | +$265K | 0.07% | 255 |
|
|
2022
Q2 | $1.8M | Buy |
8,924
+159
| +2% | +$33.9K | 0.06% | 259 |
|
|
2022
Q1 | $1.99M | Buy |
8,765
+1,895
| +28% | +$446K | 0.06% | 269 |
|
|
2021
Q4 | $1.85M | Buy |
6,870
+4,959
| +259% | +$1.23M | 0.06% | 280 |
|
|
2021
Q3 | $462K | Buy |
1,911
+93
| +5% | +$23.4K | 0.02% | 646 |
|
|
2021
Q2 | $431K | Buy |
1,818
+9
| +0.5% | +$2.05K | 0.01% | 674 |
|
|
2021
Q1 | $397K | Buy |
1,809
+11
| +0.6% | +$2.21K | 0.01% | 684 |
|
|
2020
Q4 | $315K | Sell |
1,798
-107
| -6% | -$18.5K | 0.01% | 745 |
|
|
2020
Q3 | $308K | Sell |
1,905
-177
| -9% | -$28.1K | 0.01% | 682 |
|
|
2020
Q2 | $298K | Sell |
2,082
-10
| -0.5% | -$1.38K | 0.01% | 665 |
|
|
2020
Q1 | $228K | Sell |
2,092
-59
| -3% | -$8.5K | 0.01% | 663 |
|
|
2019
Q4 | $312K | Sell |
2,151
-61
| -3% | -$8.81K | 0.01% | 670 |
|
|
2019
Q3 | $320K | Buy |
2,212
+556
| +34% | +$81.1K | 0.02% | 633 |
|
|
2019
Q2 | $246K | Sell |
1,656
-433
| -21% | -$60.4K | 0.01% | 724 |
|
|
2019
Q1 | $275K | Sell |
2,089
-1,411
| -40% | -$174K | 0.02% | 638 |
|
|
2018
Q4 | $380K | Sell |
3,500
-1,610
| -32% | -$216K | 0.02% | 469 |
|
|
2018
Q3 | $762K | Sell |
5,110
-31
| -0.6% | -$4.71K | 0.04% | 333 |
|
|
2018
Q2 | $793K | Buy |
5,141
+519
| +11% | +$78.3K | 0.05% | 308 |
|
|
2018
Q1 | $643K | Buy |
4,622
+238
| +5% | +$35K | 0.04% | 328 |
|
|
2017
Q4 | $601K | Buy |
4,384
+401
| +10% | +$53K | 0.04% | 337 |
|
|
2017
Q3 | $516K | Buy |
3,983
+176
| +5% | +$23.5K | 0.04% | 364 |
|
|
2017
Q2 | $504K | Buy |
3,807
+181
| +5% | +$22.2K | 0.04% | 369 |
|
|
2017
Q1 | $447K | Buy |
3,626
+816
| +29% | +$96.6K | 0.03% | 393 |
|
|
2016
Q4 | $310K | Sell |
2,810
-81
| -3% | -$9K | 0.02% | 481 |
|
|
2016
Q3 | $341K | Buy |
2,891
+11
| +0.4% | +$1.3K | 0.03% | 430 |
|
|
2016
Q2 | $322K | Buy |
2,880
+773
| +37% | +$83.2K | 0.03% | 444 |
|
|
2016
Q1 | $212K | Sell |
2,107
-138
| -6% | -$13.2K | 0.02% | 573 |
|
|
2015
Q4 | $238K | Buy |
+2,245
| New | +$232K | 0.02% | 547 |
|
|
2015
Q3 | – | Sell |
-2,130
| Closed | -$222K | – | 640 |
|
|
2015
Q2 | $222K | Sell |
2,130
-68
| -3% | -$7.08K | 0.02% | 544 |
|
|
2015
Q1 | $238K | Buy |
+2,198
| New | +$226K | 0.03% | 522 |
|
|
2014
Q4 | – | Sell |
-2,622
| Closed | -$230K | – | 641 |
|
|
2014
Q3 | $230K | Buy |
2,622
+118
| +5% | +$10.7K | 0.03% | 510 |
|
|
2014
Q2 | $220K | Buy |
+2,504
| New | +$217K | 0.03% | 525 |
|
Other funds holding LH
Raymond James Trust's LH Position: Q3 2024 in Review
Raymond James Trust increased its Labcorp (LH) stake by 3.4% in Q3 2024, buying an estimated $74.1K and bringing the position to 10,387 shares worth $2.32M. The position accounts for 0.05% of the portfolio, ranked #297.
Raymond James Trust first reported a position in LH in Q2 2014 and has held it in 40 quarters since. The position peaked at $2.38M in Q2 2023. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.
- Raymond James Trust held 10,387 shares of Labcorp worth $2.32M as of Q3 2024.
- Raymond James Trust bought 337 Labcorp shares in Q3 2024, an estimated $74.1K.
- Labcorp made up 0.05% of Raymond James Trust's portfolio in Q3 2024, its #297 holding.
- Raymond James Trust first reported a position in Labcorp in Q2 2014 and has held it in 40 quarters since.
- Raymond James Trust's Labcorp position peaked at $2.38M in Q2 2023.
- 918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.